Tocilizumab for the treatment of adult patients with severe COVID‐19 pneumonia: A single‐center cohort study

Coronavirus disease 2019 (COVID‐19) can lead to a massive cytokine release. The use of the anti‐interleukin‐6 receptor monoclonal antibody tocilizumab (TCZ) has been proposed in this hyperinflammatory phase, although supporting evidence is limited. We retrospectively analyzed 88 consecutive patients...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Med Virol
Main Authors: Fernández‐Ruiz, Mario, López‐Medrano, Francisco, Pérez‐Jacoiste Asín, María Asunción, Maestro de la Calle, Guillermo, Bueno, Héctor, Caro‐Teller, José Manuel, Catalán, Mercedes, de la Calle, Cristina, García‐García, Rocío, Gómez, Carlos, Laguna‐Goya, Rocío, Lizasoáin, Manuel, Martínez‐López, Joaquín, Origüen, Julia, Pablos, José Luis, Ripoll, Mar, San Juan, Rafael, Trujillo, Hernando, Lumbreras, Carlos, Aguado, José María
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2020
Assuntos:
Research Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7404673/
https://ncbi.nlm.nih.gov/pubmed/32672860
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jmv.26308
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados